Location History:
- Molndal, SE (2012)
- Mölndal, SE (2013 - 2014)
- Södertälje, SE (2024)
Company Filing History:
4 out of 1,500 
1 out of 257 
Years Active: 2012-2024
Title: Lars Anders Mikael Johansson: Innovator in Pharmaceutical Compounds
Introduction
Lars Anders Mikael Johansson is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific biological pathways. With a total of 4 patents to his name, Johansson's work has the potential to impact therapeutic strategies for various diseases.
Latest Patents
Johansson's latest patents include innovative compounds that are designed to inhibit NLRP3 inflammasome activity. These compounds, described in his specifications, are useful as therapeutic agents for treating or preventing diseases associated with the NLRP3 inflammasome. Additionally, he has developed azetidinyl compounds that are aimed at addressing melanin-concentrating hormone-related conditions. These patents reflect his commitment to advancing medical science through innovative chemical solutions.
Career Highlights
Throughout his career, Johansson has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with AstraZeneca and Mitsubishi Tanabe Pharma Corporation. His experience in these organizations has allowed him to collaborate with leading experts and contribute to groundbreaking research in drug development.
Collaborations
Johansson has collaborated with several professionals in his field, including Robert Andrew Judkins and Lanna Li. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.
Conclusion
Lars Anders Mikael Johansson is a distinguished inventor whose contributions to pharmaceutical compounds are noteworthy. His innovative patents and collaborations reflect his dedication to improving healthcare through scientific advancements.